Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2

• Sigve Andersen ,

  * E-mail: sigve.andersen@uit.no

  Affiliations Institute of Clinical Medicine, University of Tromso, Tromso, Norway, Department of Oncology, University Hospital of North Norway, Tromso, Norway

  ⨯
• Tom Donnem,

  Affiliations Institute of Clinical Medicine, University of Tromso, Tromso, Norway, Department of Oncology, University Hospital of North Norway, Tromso, Norway

  ⨯
• Khalid Al-Shibli,

  Affiliations Institute of Medical Biology, University of Tromso, Tromso, Norway, Department of Pathology, Nordland Central Hospital, Bodo, Norway

  ⨯
• Samer Al-Saad,

  Affiliations Institute of Medical Biology, University of Tromso, Tromso, Norway, Department of Pathology, University Hospital of North Norway, Tromso, Norway

  ⨯
• Helge Stenvold,

  Affiliations Institute of Clinical Medicine, University of Tromso, Tromso, Norway, Department of Oncology, University Hospital of North Norway, Tromso, Norway

  ⨯
• Lill-Tove Busund,

  Affiliations Institute of Medical Biology, University of Tromso, Tromso, Norway, Department of Pathology, University Hospital of North Norway, Tromso, Norway

  ⨯
• Roy M. Bremnes

  Affiliations Institute of Clinical Medicine, University of Tromso, Tromso, Norway, Department of Oncology, University Hospital of North Norway, Tromso, Norway

  ⨯